Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Volume vs Concentration in ESPB for Mastectomy
NCT05813158Phase 3Completed
- Sponsor
- Cairo University
- Start
- Sep 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Total dose of morphine needed postoperatively at 24 hours. Started Sep 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05813158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05813158.